Upstream Processing

Oct 01, 2017
BioPharm International
This study is an attempt to produce a fusion protein by binding the fragment NT-gp96 in upstream of sequence of the N terminal fragment (NT300) of the NS5B gene in an expression vector.
Oct 01, 2017
BioPharm International
Detecting viral contaminants in biologic-based medicines—and identifying their source—requires a holistic testing approach.
Sep 15, 2017
BioPharm International
Consider automation early in the rollout of clinical translation and scale up of clinical-trial protocols.
Sep 15, 2017
BioPharm International
Traditional planar culture formats are being superceded by microcarriers for large-scale cell therapy manufacturing.
Sep 01, 2017
BioPharm International
Modeling tools help process engineers optimize a biopharmaceutical facility’s capacity.
Aug 28, 2017
By BioPharm International Editors
FDA noted in a recent inspection that US Stem Cell Clinic was processing and administering stem cell treatments that were neither reviewed nor approved by the agency.
Aug 23, 2017
By BioPharm International Editors
AstraZeneca and Champions will develop new cohorts of patient-derived xenograft models to be used in oncology programs in breast and lung cancer as well as for use in other academic and industry applications.
Aug 21, 2017
By BioPharm International Editors
The first program of this collaboration will focus on the development of a candidate for severe acute pancreatitis.
Aug 10, 2017
By BioPharm International Editors
Pfizer will invest $100 million to expand its manufacturing facilities in Sanford, North Carolina.
Aug 01, 2017
BioPharm International
Managing and prioritizing risk is essential to ensuring raw material quality. USP is developing new guidelines to make the work easier.
native1_300x100
lorem ipsum